Yancheva D, Argirova M, Georgieva I, Milanova V, Guncheva M, Rangelov M
Molecules. 2024; 29(10).
PMID: 38792260
PMC: 11123699.
DOI: 10.3390/molecules29102400.
Kale S, Jedhe G, Meshram S, Santra M, Hamel E, Sanjayan G
Bioorg Med Chem Lett. 2015; 25(9):1982-5.
PMID: 25817588
PMC: 4416488.
DOI: 10.1016/j.bmcl.2015.03.019.
Bronsvoort B, Makepeace B, Renz A, Tanya V, Fleckenstein L, Ekale D
Parasit Vectors. 2008; 1(1):18.
PMID: 18570639
PMC: 2464590.
DOI: 10.1186/1756-3305-1-18.
Katiyar S, Edlind T
Antimicrob Agents Chemother. 1998; 41(12):2729-32.
PMID: 9420047
PMC: 164197.
DOI: 10.1128/AAC.41.12.2729.
Stitt A, Fairweather I
Parasitol Res. 1993; 79(7):529-36.
PMID: 8278333
DOI: 10.1007/BF00932235.
In vitro susceptibility of the opportunistic fungus Cryptococcus neoformans to anthelmintic benzimidazoles.
Cruz M, Bartlett M, Edlind T
Antimicrob Agents Chemother. 1994; 38(2):378-80.
PMID: 8192471
PMC: 284462.
DOI: 10.1128/AAC.38.2.378.
Antiprotozoal activities of benzimidazoles and correlations with beta-tubulin sequence.
Katiyar S, Gordon V, McLAUGHLIN G, Edlind T
Antimicrob Agents Chemother. 1994; 38(9):2086-90.
PMID: 7811023
PMC: 284688.
DOI: 10.1128/AAC.38.9.2086.
Clinical pharmacokinetics of anthelmintic drugs.
Edwards G, Breckenridge A
Clin Pharmacokinet. 1988; 15(2):67-93.
PMID: 3064952
DOI: 10.2165/00003088-198815020-00001.
Fasciola hepatica: localization and partial characterization of tubulin.
Stitt A, Fairweather I, Trudgett A, Johnston C
Parasitol Res. 1992; 78(2):103-7.
PMID: 1557320
DOI: 10.1007/BF00931649.
Cytotoxicity of mebendazole against established cell lines from the human, rat, and mouse liver.
Higa F, Kitsukawa K, Gaja M, Tateyama M, Shikiya K, Shigeno Y
Arch Toxicol. 1992; 66(3):224-7.
PMID: 1497489
DOI: 10.1007/BF01974020.
Effects of multiple doses of isoprinosine on Echinococcus multilocularis metacestodes.
Sarciron M, Delabre I, Walbaum S, Raynaud G, Petavy A
Antimicrob Agents Chemother. 1992; 36(1):191-4.
PMID: 1375448
PMC: 189252.
DOI: 10.1128/AAC.36.1.191.
